Therefore, the current study aims to investigate the therapeutic potential of NIC in TAA-induced liver fibrosis in rats, focusing on its ability to regulate the AMPK/SIRT-1/HIF-1α axis and promote liver regeneration. Here, HIF1A is linked to Hepatic fibrosis.